SUBSCRIBE
SUBSCRIBE
News   Deals

Introgen Therapeutics, Inc. Strengthens Cash Position, Sells Shares in Silence Therapeutics plc

January 17, 2008 | 
1 min read

AUSTIN, Texas--(BUSINESS WIRE)--Today, Introgen Therapeutics, Inc. (NASDAQ:INGN) announced it sold approximately 7,478,000 shares of Silence Therapeutics plc. (LSE:SLN) for net proceeds to Introgen of approximately $7,549,000.

Mergers & acquisitions
MORE ON THIS TOPIC
Creative background
Deals
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal
February 28, 2025
 · 
2 min read
 · 
Annalee Armstrong
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
February 27, 2025
 · 
1 min read
 · 
Lori Ellis
Two human hands with a gesture of a handshake agreement and dollar banknotes with dollar signs on a colored background. Concept of business contract or agreement. Collage art
Editorial
The BioSpace Book Club Investigates the Biggest Deals of All Time
February 26, 2025
 · 
3 min read
 · 
Annalee Armstrong
Health saving account, HSA, financial plan saving for medical expense or medicare cost and benefits concept, doctor with stethoscope standing with huge pink piggy bank or coin bank with medical sign.
GLP-1
As Money Pours Into Weight Loss Drugs, Physicians Prioritize Efficacy, Access
February 26, 2025
 · 
5 min read
 · 
Annalee Armstrong